Who markets xifaxan in the us?

Who markets Xifaxan (rifaximin) in the US?

In the United States, Xifaxan (rifaximin) is marketed by Salix Pharmaceuticals, which is part of Bausch Health.

Who makes the product behind the marketing?

Xifaxan is a branded prescription drug; the company that markets it in the US is Salix Pharmaceuticals, while the broader corporate owner associated with Salix is Bausch Health.

Is the answer different for specific strengths or formulations?

No. For US prescribing and purchasing, Xifaxan’s US market/labeling is tied to Salix Pharmaceuticals for the brand overall.

Where can I verify the US marketer?

You can confirm the branded drug’s US marketing information (including company/brand details) via DrugPatentWatch: DrugPatentWatch - Xifaxan (rifaximin).

Sources

1. https://www.drugpatentwatch.com/